Revance Therapeutics shares owned by EULAV Asset Management
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by EULAV Asset Management
from 13F filings
Historical chart of EULAV Asset Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by EULAV Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by EULAV Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $6.9M | 600k | 11.47 |
| 2023-06-30 | $4.0M | 160k | 25.31 |
| 2023-03-31 | $3.4M | 105k | 32.21 |
| 2022-12-31 | $3.1M | 170k | 18.46 |